Showing 1 - 10 of 22
Persistent link: https://www.econbiz.de/10010228492
Persistent link: https://www.econbiz.de/10011868821
the value and subsequent reimbursement of new and existing drugs, as well as reforms to obtain low prices for generic …
Persistent link: https://www.econbiz.de/10005243086
Persistent link: https://www.econbiz.de/10009404204
character of a monopoly system, leading to reimbursement decisions where usage of new medicines is limited to subgroups and not … system. The aim of this article is to suggest a modification to the current reimbursement system in Sweden where payment for …
Persistent link: https://www.econbiz.de/10010552620
Persistent link: https://www.econbiz.de/10010614333
Persistent link: https://www.econbiz.de/10010614367
costly orphan drugs because access depends primarily on co-payments, reimbursement policies and prices. The objective of this …
Persistent link: https://www.econbiz.de/10010614375
This work aims to provide a systematic and updated survey of original scientific studies on the effect of the introduction of reference pricing (RP) policies in Organisation for Economic Co-operation and Development (OECD) countries. We searched PubMed, EconLit and Web of Knowledge for articles...
Persistent link: https://www.econbiz.de/10010614402
reimbursement system. Sweden has, as most other countries, seen a large increase in the expenditures on drugs in recent years. The … responsibility for the cost of drugs in Sweden has recently been decentralized to the county council level. The reimbursement system … currently not mandatory in Swedish price and reimbursement negotiations but are nonetheless important, particularly in …
Persistent link: https://www.econbiz.de/10010758662